nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—NFATC1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAUR—meningioma	0.0536	0.0536	CbGpPWpGaD
Pseudoephedrine—NFATC1—Ectoderm Differentiation—NF2—meningioma	0.0494	0.0494	CbGpPWpGaD
Pseudoephedrine—NFATC1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—meningioma	0.0376	0.0376	CbGpPWpGaD
Pseudoephedrine—IL2—Aryl Hydrocarbon Receptor Pathway—HES1—meningioma	0.0322	0.0322	CbGpPWpGaD
Pseudoephedrine—TNF—Cellular roles of Anthrax toxin—PGR—meningioma	0.0316	0.0316	CbGpPWpGaD
Pseudoephedrine—TNF—Amyotrophic lateral sclerosis (ALS)—CST3—meningioma	0.0237	0.0237	CbGpPWpGaD
Pseudoephedrine—IL2—SHP2 signaling—PDGFB—meningioma	0.0229	0.0229	CbGpPWpGaD
Pseudoephedrine—IL2—T-Cell Receptor and Co-stimulatory Signaling—PTEN—meningioma	0.0228	0.0228	CbGpPWpGaD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—PLAU—meningioma	0.0226	0.0226	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—PLAU—meningioma	0.0191	0.0191	CbGpPWpGaD
Pseudoephedrine—TNF—amb2 Integrin signaling—PLAUR—meningioma	0.019	0.019	CbGpPWpGaD
Pseudoephedrine—NFATC1—BCR signaling pathway—PTEN—meningioma	0.0138	0.0138	CbGpPWpGaD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—PTEN—meningioma	0.0133	0.0133	CbGpPWpGaD
Pseudoephedrine—TNF—amb2 Integrin signaling—PLAU—meningioma	0.0133	0.0133	CbGpPWpGaD
Pseudoephedrine—IL2—T-Cell Receptor and Co-stimulatory Signaling—AKT1—meningioma	0.0131	0.0131	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor Pathway—HES1—meningioma	0.012	0.012	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—PDGFB—meningioma	0.0116	0.0116	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—PTEN—meningioma	0.0113	0.0113	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—PDGFB—meningioma	0.0111	0.0111	CbGpPWpGaD
Pseudoephedrine—IL2—IL2 signaling events mediated by PI3K—AKT1—meningioma	0.0108	0.0108	CbGpPWpGaD
Pseudoephedrine—IL2—IL-5 Signaling Pathway—AKT1—meningioma	0.0102	0.0102	CbGpPWpGaD
Pseudoephedrine—IL2—IL-2 Signaling Pathway—AKT1—meningioma	0.00976	0.00976	CbGpPWpGaD
Pseudoephedrine—NFATC1—RANKL/RANK Signaling Pathway—AKT1—meningioma	0.0093	0.0093	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CTSL—meningioma	0.00927	0.00927	CbGpPWpGaD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—TP53—meningioma	0.00908	0.00908	CbGpPWpGaD
Pseudoephedrine—IL2—G beta:gamma signalling through PI3Kgamma—AKT1—meningioma	0.00877	0.00877	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCRs, Other—SMO—meningioma	0.00874	0.00874	CbGpPWpGaD
Pseudoephedrine—IL2—GPVI-mediated activation cascade—AKT1—meningioma	0.00863	0.00863	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—AP1B1—meningioma	0.00838	0.00838	CbGpPWpGaD
Pseudoephedrine—IL2—G-protein beta:gamma signalling—AKT1—meningioma	0.00836	0.00836	CbGpPWpGaD
Pseudoephedrine—ADRB1—G alpha (s) signalling events—TSHB—meningioma	0.00821	0.00821	CbGpPWpGaD
Pseudoephedrine—IL2—Folate Metabolism—TP53—meningioma	0.00805	0.00805	CbGpPWpGaD
Pseudoephedrine—ADRB2—G alpha (s) signalling events—TSHB—meningioma	0.00803	0.00803	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—TP53—meningioma	0.008	0.008	CbGpPWpGaD
Pseudoephedrine—NFATC1—BCR signaling pathway—AKT1—meningioma	0.00794	0.00794	CbGpPWpGaD
Pseudoephedrine—IL2—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00785	0.00785	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—AP1B1—meningioma	0.00774	0.00774	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—TP53—meningioma	0.00768	0.00768	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—ERBB2—meningioma	0.00743	0.00743	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—CST3—meningioma	0.00725	0.00725	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—AP1B1—meningioma	0.00709	0.00709	CbGpPWpGaD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—TP53—meningioma	0.00677	0.00677	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—AKT1—meningioma	0.00676	0.00676	CbGpPWpGaD
Pseudoephedrine—IL2—Regulation of Telomerase—AKT1—meningioma	0.00664	0.00664	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00652	0.00652	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.00634	0.00634	CbGpPWpGaD
Pseudoephedrine—NFATC1—TCR Signaling Pathway—AKT1—meningioma	0.00627	0.00627	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00586	0.00586	CbGpPWpGaD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—AKT1—meningioma	0.00572	0.00572	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD34—meningioma	0.00566	0.00566	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—PLAUR—meningioma	0.0056	0.0056	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CTSL—meningioma	0.0054	0.0054	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—TSHB—meningioma	0.00537	0.00537	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—HES1—meningioma	0.00522	0.00522	CbGpPWpGaD
Pseudoephedrine—IL2—Corticotropin-releasing hormone—AKT1—meningioma	0.00521	0.00521	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—TP53—meningioma	0.00506	0.00506	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—TSHB—meningioma	0.00487	0.00487	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD34—meningioma	0.00479	0.00479	CbGpPWpGaD
Pseudoephedrine—SLC6A4—NRF2 pathway—PDGFB—meningioma	0.00471	0.00471	CbGpPWpGaD
Pseudoephedrine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—meningioma	0.00466	0.00466	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CST3—meningioma	0.0046	0.0046	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CTSL—meningioma	0.00457	0.00457	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—HES1—meningioma	0.00451	0.00451	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—TP53—meningioma	0.00451	0.00451	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—PDGFB—meningioma	0.00431	0.00431	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—HES1—meningioma	0.00428	0.00428	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—SMO—meningioma	0.00414	0.00414	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—PDGFB—meningioma	0.00405	0.00405	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—PDGFB—meningioma	0.00405	0.00405	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—PLAU—meningioma	0.00393	0.00393	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHB—meningioma	0.00391	0.00391	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHB—meningioma	0.00383	0.00383	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—AKT1—meningioma	0.00381	0.00381	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.00365	0.00365	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—PDGFB—meningioma	0.00364	0.00364	CbGpPWpGaD
Pseudoephedrine—TNF—TWEAK Signaling Pathway—AKT1—meningioma	0.00363	0.00363	CbGpPWpGaD
Pseudoephedrine—SLC6A3—NRF2 pathway—PDGFB—meningioma	0.00359	0.00359	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TSHB—meningioma	0.0034	0.0034	CbGpPWpGaD
Pseudoephedrine—TNF—Ceramide signaling pathway—AKT1—meningioma	0.00326	0.00326	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHB—meningioma	0.00317	0.00317	CbGpPWpGaD
Pseudoephedrine—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—meningioma	0.00316	0.00316	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—meningioma	0.00302	0.00302	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—TP53—meningioma	0.003	0.003	CbGpPWpGaD
Pseudoephedrine—NFATC1—RNF mutants show enhanced WNT signaling and proliferation—AKT1—meningioma	0.00299	0.00299	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—TSHB—meningioma	0.00298	0.00298	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHB—meningioma	0.00294	0.00294	CbGpPWpGaD
Pseudoephedrine—TNF—Cardiac Hypertrophic Response—AKT1—meningioma	0.00293	0.00293	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—TSHB—meningioma	0.00291	0.00291	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SMO—meningioma	0.00289	0.00289	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—ERBB2—meningioma	0.00289	0.00289	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TSHB—meningioma	0.00288	0.00288	CbGpPWpGaD
Pseudoephedrine—TNF—Caspase Cascade in Apoptosis—AKT1—meningioma	0.00284	0.00284	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by WNT in cancer—AKT1—meningioma	0.00278	0.00278	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PGR—meningioma	0.00277	0.00277	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HES1—meningioma	0.00271	0.00271	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—meningioma	0.00259	0.00259	CbGpPWpGaD
Pseudoephedrine—IL2—Platelet activation, signaling and aggregation—AKT1—meningioma	0.00259	0.00259	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—meningioma	0.00255	0.00255	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—SMO—meningioma	0.00253	0.00253	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—PDGFB—meningioma	0.00251	0.00251	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—SMO—meningioma	0.00248	0.00248	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—meningioma	0.00247	0.00247	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—PTEN—meningioma	0.00246	0.00246	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SMO—meningioma	0.00245	0.00245	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—TSHB—meningioma	0.00241	0.00241	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PGR—meningioma	0.00235	0.00235	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PDGFB—meningioma	0.00232	0.00232	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by Wnt—AKT1—meningioma	0.00229	0.00229	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—TSHB—meningioma	0.00224	0.00224	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.0022	0.0022	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—PDGFB—meningioma	0.00212	0.00212	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—meningioma	0.00209	0.00209	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—AKT1—meningioma	0.00209	0.00209	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—PTEN—meningioma	0.00209	0.00209	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—SMO—meningioma	0.00205	0.00205	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—meningioma	0.00197	0.00197	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—AKT1—meningioma	0.00194	0.00194	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—SMO—meningioma	0.0019	0.0019	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HES1—meningioma	0.0019	0.0019	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ALAD—meningioma	0.00189	0.00189	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—meningioma	0.00188	0.00188	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00188	0.00188	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.00185	0.00185	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—HES1—meningioma	0.00179	0.00179	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—AKT1—meningioma	0.00179	0.00179	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TSHB—meningioma	0.00168	0.00168	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—ERBB2—meningioma	0.00168	0.00168	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—AKT1—meningioma	0.00167	0.00167	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TSHB—meningioma	0.00165	0.00165	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PDGFB—meningioma	0.00162	0.00162	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HES1—meningioma	0.0016	0.0016	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—meningioma	0.00158	0.00158	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ERBB2—meningioma	0.00155	0.00155	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TSHB—meningioma	0.00153	0.00153	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—meningioma	0.00151	0.00151	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TSHB—meningioma	0.0015	0.0015	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—PTEN—meningioma	0.00143	0.00143	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—meningioma	0.00142	0.00142	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ERBB2—meningioma	0.00142	0.00142	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—meningioma	0.00142	0.00142	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—AKT1—meningioma	0.00142	0.00142	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.00139	0.00139	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PDGFB—meningioma	0.00137	0.00137	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TSHB—meningioma	0.00136	0.00136	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—AKT1—meningioma	0.00133	0.00133	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTEN—meningioma	0.00132	0.00132	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PLAUR—meningioma	0.00132	0.00132	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—SMO—meningioma	0.0013	0.0013	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00128	0.00128	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—AKT1—meningioma	0.00128	0.00128	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—SMO—meningioma	0.00127	0.00127	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TSHB—meningioma	0.00127	0.00127	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALAD—meningioma	0.00126	0.00126	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TSHB—meningioma	0.00124	0.00124	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TSHB—meningioma	0.00122	0.00122	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—PTEN—meningioma	0.00121	0.00121	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—AKT1—meningioma	0.0012	0.0012	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TSHB—meningioma	0.00115	0.00115	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ERBB2—meningioma	0.00109	0.00109	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00108	0.00108	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—SMO—meningioma	0.00105	0.00105	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—ERBB2—meningioma	0.00103	0.00103	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—SMO—meningioma	0.000977	0.000977	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PDGFB—meningioma	0.000955	0.000955	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PTEN—meningioma	0.000927	0.000927	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PLAU—meningioma	0.000926	0.000926	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ERBB2—meningioma	0.00092	0.00092	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TSHB—meningioma	0.000903	0.000903	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TSHB—meningioma	0.000883	0.000883	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—AKT1—meningioma	0.000842	0.000842	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—AKT1—meningioma	0.000826	0.000826	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALAD—meningioma	0.000821	0.000821	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TSHB—meningioma	0.000812	0.000812	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PTEN—meningioma	0.000784	0.000784	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SMO—meningioma	0.000768	0.000768	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—AKT1—meningioma	0.000765	0.000765	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—AKT1—meningioma	0.000763	0.000763	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SMO—meningioma	0.000751	0.000751	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PGR—meningioma	0.000736	0.000736	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TSHB—meningioma	0.000731	0.000731	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PGR—meningioma	0.00072	0.00072	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—AKT1—meningioma	0.000699	0.000699	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TSHB—meningioma	0.000679	0.000679	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—meningioma	0.000633	0.000633	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SMO—meningioma	0.000621	0.000621	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—meningioma	0.00061	0.00061	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PGR—meningioma	0.000596	0.000596	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SMO—meningioma	0.000577	0.000577	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PGR—meningioma	0.000553	0.000553	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—meningioma	0.000535	0.000535	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AKT1—meningioma	0.000534	0.000534	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TSHB—meningioma	0.000529	0.000529	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—AKT1—meningioma	0.000506	0.000506	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HES1—meningioma	0.000503	0.000503	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HES1—meningioma	0.000492	0.000492	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—meningioma	0.000452	0.000452	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PDGFB—meningioma	0.00043	0.00043	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PDGFB—meningioma	0.000421	0.000421	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HES1—meningioma	0.000407	0.000407	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HES1—meningioma	0.000378	0.000378	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—meningioma	0.000372	0.000372	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PDGFB—meningioma	0.000348	0.000348	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTEN—meningioma	0.000331	0.000331	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDGFB—meningioma	0.000324	0.000324	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—meningioma	0.000314	0.000314	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB2—meningioma	0.000289	0.000289	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB2—meningioma	0.000282	0.000282	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—meningioma	0.000264	0.000264	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—meningioma	0.000259	0.000259	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTEN—meningioma	0.000246	0.000246	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTEN—meningioma	0.000241	0.000241	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—meningioma	0.00024	0.00024	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—meningioma	0.000235	0.000235	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB2—meningioma	0.000233	0.000233	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTEN—meningioma	0.000221	0.000221	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB2—meningioma	0.000217	0.000217	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—meningioma	0.000214	0.000214	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTEN—meningioma	0.000199	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—meningioma	0.000199	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—meningioma	0.000194	0.000194	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—meningioma	0.000191	0.000191	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTEN—meningioma	0.000185	0.000185	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—meningioma	0.00018	0.00018	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—meningioma	0.000168	0.000168	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—meningioma	0.000164	0.000164	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTEN—meningioma	0.000144	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—meningioma	0.000142	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—meningioma	0.000139	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—meningioma	0.000136	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—meningioma	0.000127	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—meningioma	0.000126	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—meningioma	0.000115	0.000115	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—meningioma	0.000107	0.000107	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—meningioma	8.31e-05	8.31e-05	CbGpPWpGaD
